Wegovy 1.7mg: Understanding This Dose Stage

Wegovy (semaglutide) is a once-weekly injectable prescription medicine and a GLP-1 receptor agonist. It is typically introduced at a low starting dose and increased in stages over several months, with each step intended to allow the body to adjust before moving higher. The 1.7mg strength sits just below the maximum maintenance dose of 2.4mg commonly referenced in prescribing information.

How titration generally works

The step-up schedule exists to help manage commonly reported side effects — particularly gastrointestinal ones such as nausea, indigestion, or changes in bowel habits — while allowing the medicine's effects on appetite to become established. According to information published on the electronic Medicines Compendium, dose progression follows a defined schedule that your prescriber will apply based on your tolerance and response. The timing and whether to continue escalating is always a clinical decision.

It is worth noting that not everyone reaches the 1.7mg or 2.4mg stage — some people find an earlier dose works well for them, and their prescriber may decide to maintain that level. If you have questions about where you are in your schedule, the right place to ask is your prescriber or doctor.

About purchase and supply

Wegovy is a prescription-only medicine. GLP Trackr is a tracking and journaling app — it does not sell, supply, or source Wegovy or any other medicine at any dose. If you are looking for information about obtaining your prescription, that conversation belongs with a registered pharmacy and your prescriber in your country. For context on how different dose stages compare across medicines, you may find it useful to read about the Wegovy 1.7mg equivalent in Mounjaro — though any switch between medicines is purely a prescriber decision.

For general background on how dose stages work across GLP-1 medicines, our guide to Mounjaro dosing covers related titration principles that many people find helpful context.

Staying consistent week to week is one of the most important — and easily overlooked — parts of any injectable treatment schedule. GLP Trackr's dose logging feature is built specifically for this: each time you take your injection, you can record the date, time, and dose strength, so you always have a clear record of where you are in your schedule.

As you move through titration stages, this log becomes genuinely useful. You can look back and see exactly when each dose change happened, which makes it much easier to have an informed conversation with your prescriber at your next appointment. The app also lets you set a weekly dose reminder, so a dose is never accidentally missed — particularly helpful during busy weeks when a once-weekly schedule can slip the mind.

If you experience side effects at the 1.7mg stage — something many people do report as doses increase — the side-effect tracker lets you log symptoms like nausea or fatigue alongside your dose history. Over time, patterns become visible: for example, whether symptoms tend to peak on the day after your injection and ease by mid-week. That kind of logged evidence is far more useful to bring to a prescriber appointment than trying to recall it from memory. You can also explore managing the cost of your Wegovy prescription as your dose increases.

For those curious about how semaglutide compares to tirzepatide at similar stages, our page on Mounjaro 7mg offers useful parallel context — though again, any medicine decisions rest entirely with your prescriber.

Any decision about your dose — including whether to move to 1.7mg, stay at your current level, or adjust your schedule — should be made with your prescriber, never on your own. GLP Trackr helps you record your journey accurately so those conversations are better informed; it is not a substitute for clinical guidance.

Keep a clear record of every dose, spot patterns in how you feel, and bring sharper insight to your next prescriber appointment — GLP Trackr is free to try for 7 days on the App Store and Google Play.